Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
detroit blog main
national
5
×
national blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
startups
5
×
texas blog main
5
×
texas top stories
venture capital
5
×
wisconsin blog main
boulder/denver blog main
detroit top stories
indiana blog main
new york top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
wisconsin top stories
biotech
boston top stories
boulder/denver top stories
cancer
fda
indiana top stories
life sciences
biogen
clinical trials
deals
deerfield management
europe blog main
europe top stories
gilead sciences
ipo
medical devices
What
bio
roundup
covid
developing
fda
investors
ipo
medicines
acquisitions
activity
ahead
announced
approvals
asco
attributes
biogen
branded
business
ceo
charm
choices
clamped
collabs
comes
commissioner
company
consumers
control
costly
counterweight
daniel
deal
delays
drugs
economic
effect
elevatebio
entrepreneur
execs
external
Language
unset
Current search:
startups
×
" texas blog main "
×
" venture capital "
×
national
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
